2 Minnesota companies work on drug-coated balloons

02/15/2009 | Star Tribune (Minneapolis-St. Paul, Minn.)

Lutonix and Possis Medical are separately working to develop drug-coated balloons that could serve as a lower-cost alternative to drug-eluting stents used in treating vascular diseases. Lutonix plans to begin clinical trials in Europe for its device this year and hopes to secure FDA approval by 2014. A spokesman for Possis Medical said the company plans to begin a clinical study of its product in the U.S. in the "near future."

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA